Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) fell 23.1% during trading on Monday . The company traded as low as GBX 10.50 ($0.14) and last traded at GBX 11.30 ($0.15). 185,940 shares traded hands during mid-day trading, a decline of 23% from the average session volume of 241,876 shares. The stock had previously closed at GBX 14.70 ($0.20).
Celadon Pharmaceuticals Stock Down 23.1%
The business’s 50-day moving average is GBX 7.03 and its two-hundred day moving average is GBX 13.07. The firm has a market capitalization of £6.93 million, a price-to-earnings ratio of -1.42 and a beta of -0.26. The company has a debt-to-equity ratio of 196.67, a quick ratio of 6.97 and a current ratio of 1.92.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Palantir Defies Bears, Leads S&P 500 in 2025
- Expert Stock Trading Psychology Tips
- Why Analysts Are Bullish on Celsius Stock After 30% Drop
- EV Stocks and How to Profit from Them
- AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
